Cell Cycle 2011-10-01

FoxM1 knockdown sensitizes human cancer cells to proteasome inhibitor-induced apoptosis but not to autophagy.

Bulbul Pandit, Andrei L Gartel

Index: Cell Cycle 10(19) , 3269-73, (2011)

Full Text: HTML

Abstract

Apoptosis has been widely accepted as the primary mechanism of drug-induced cell death. Recently, a second type of cell death pathway has been demonstrated: autophagy, also called programmed type II cell death. Autophagy is a highly regulated process, by which selected components of a cell are degraded. It primarily functions as a cell survival mechanism under stress. However, persistent stress can also promote extensive autophagy leading to cell death. Forkhead box M1 (FoxM1), an oncogenic transcription factor that is abundantly expressed in a wide range of human cancers. Here we evaluated the role of FoxM1 in sensitivity of human cancer cells to proteasome inhibitor-induced apoptosis and autophagy. We found that FoxM1 knockdown sensitized the human cancer cells to apoptotic cell death induced by proteasome inhibitors, such as, MG132, bortezomib and thiostrepton, while it did not affect the levels of autophagy following treatment with these drugs.© 2011 Landes Bioscience

Related Compounds

  • Thiostrepton

Related Articles:

ppGpp inhibits peptide elongation cycle of chloroplast translation system in vitro.

2012-01-01

[Plant Mol. Biol. 78(1-2) , 185-96, (2012)]

Development of a vector and host system and characterization of replication of plasmid pSQ10 in moderately halophilic Nocardiopsis.

2011-09-01

[Acta Biochim. Biophys. Sin. (Shanghai) 43(9) , 738-43, (2011)]

Thiostrepton, proteasome inhibitors and FOXM1.

2011-12-15

[Cell Cycle 10(24) , 4341-2, (2011)]

Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.

2011-01-01

[PLoS ONE 6 , e23790, (2011)]

Thiostrepton is an inducer of oxidative and proteotoxic stress that impairs viability of human melanoma cells but not primary melanocytes.

2012-05-01

[Biochem. Pharmacol. 83(9) , 1229-40, (2012)]

More Articles...